Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Everolimus-D4 Solution, 100 μg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco E0701ML
Description
A stable-labeled internal standard for the immunosuppressant Everolimus, marketed as Zortress™ and Certican for use in organ transplantation and Afinitor™ for treatment of kidney and pancreatic cancers. Clinical laboratories quantitate everolimus levels in patient whole blood samples using LC-MS/MS. While many everolimus LC-MS/MS methods use 32-desmethoxyrapamycin or ascomycin as an internal standard, higher levels of variability / lower levels of reproducibility may occur in the analysis along with the potential for interferences. Use of a stable-labeled analog of everolimus is the best choice to minimize variability or mitigate any potential interference in LC-MS/MS analysis.
Specifications
| 75-05-8 , 1338452-54-2 | |
| UN 1648 3 / PGII | |
| 962.25 | |
| 1 mL |
| C53H79NO14D4 | |
| 100 μg/mL in acetonitrile | |
| Ampule | |
| 2°C (35.6°F) - closed cup |
Safety and Handling
H332-H319
H312
EINECSNumber : 200-835-2
Recommended Storage : -70°C
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?
CERILLIANT is a registered trademark of Cerilliant Corporation